Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Prognostic Significance of Chads2 and Cha2ds2-Vasc Scores to Predict Unfavorable Outcomes in Hospitalized Patients With Covid-19 Publisher



Montazeri M1 ; Keykhaei M2 ; Rashedi S2 ; Saleh SK3 ; Pazoki M4 ; Hadadi A1, 5 ; Sharifnia SH6 ; Sotoodehnia M7 ; Ajloo S2 ; Kafan S4 ; Ashraf H2, 8
Authors

Source: Journal of Cardiovascular and Thoracic Research Published:2022


Abstract

Introduction: Owing to the imposed burden of the coronavirus disease 2019 (COVID-19), the need for stratifying the prognosis of patients has never been timelier. Hence, we aimed to ascertain the value of CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-M (one point for male instead of female) scores to predict unfavorable outcomes in COVID-19 patients. Methods: We enrolled consecutive patients above 18 years of age with confirmed COVID-19, who were admitted between February 16 and November 1, 2020. The primary endpoint of this study was three-month all-cause mortality. The secondary endpoints were considered four major in-hospital clinical features, including acute respiratory distress syndrome, cardiac injury, acute kidney injury, and mechanical ventilation. Results: A total of 1,406 hospitalized COVID-19 patients were studied, among which 301 (21.40%) patients died during the follow-up period. Regarding the risk scores, CHADS2 ≥ 1, CHA2DS2-VASc ≥ 2, and CHA2DS2-VASc-M ≥ 2 were significantly associated with mortality. The performance of all risk scores for predicting mortality was satisfactory (area under the curve: 0.668, 0.668, and 0.681, respectively). Appraising secondary endpoints, we found that all three risk scores were associated with increased risk of acute respiratory distress syndrome, cardiac injury, acute kidney injury, and mechanical ventilation. Lastly, we revealed that all risk scores were significantly correlated with serum levels of laboratory biomarkers. Conclusion: Our analysis illustrated that the CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-M scores could aid prognostication of unfavorable outcomes in COVID-19 patients. Therefore, these easily calculable methods could be integrated into the overall therapeutic strategy to guide the COVID-19 management more accurately. © 2022 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Other Related Docs
10. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)
13. Factors Associated With the Poor Outcomes in Diabetic Patients With Covid-19, Journal of Diabetes and Metabolic Disorders (2020)